News

Filter

Current filters:

Aspen Pharmacare

1 to 9 of 20 results

Mylan to acquire US rights to Arixtra Injection from Aspen

Mylan to acquire US rights to Arixtra Injection from Aspen

10-09-2014

US generic drugs major Mylan has entered into an agreement to acquire the US commercialization, marketing…

ArixtraAspen PharmacareCardio-vascularGenericsGlaxoSmithKlineMergers & AcquisitionsMylanUSA

GlaxoSmithKline cashes in $694 million of Aspen shares

GlaxoSmithKline cashes in $694 million of Aspen shares

21-11-2013

UK pharma giant GlaxoSmithKline said yesterday that it has agreed to the sale of 28.2 million ordinary…

Aspen PharmacareFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Aspen Pharma reports rise in profits from new product launches

11-09-2013

South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site

19-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

South Africa's drugmakers bemoan low medicine price hikes

27-01-2013

South Africa's Department of Health announced last week that pharmaceutical companies will be allowed…

Adcock IngramAspen PharmacareGenericsPharmaceuticalPricingRest of the World

1 to 9 of 20 results

COMPANY SPOTLIGHT

Menarini

Back to top